The factory had to scale back because demand wasn't that high
In a Curitiba laboratory, Brazilian scientist Luciano Moreira has spent over a decade cultivating a quiet biological revolution — mosquitoes engineered by nature itself to disrupt the spread of dengue. The method works, and works well, yet the virus outpaces the remedy: climate change is opening new frontiers for disease even as bureaucracy and logistical strain slow the deployment of the insects that could stop it. More than 200 million Brazilians remain exposed, and the distance between what science can offer and what institutions can deliver has become, in itself, a public health crisis.
- A 2024 dengue outbreak killed more than 6,000 Brazilians, and climate change is now pushing the virus into southern regions that were once too cold to sustain it.
- Brazil's Curitiba bio-factory can produce 100 million Wolbachia-infected mosquito eggs per week, yet it was forced to scale back production because government demand failed to match its capacity.
- In Rio de Janeiro, the program has been undermined by poor inter-agency coordination, larvicide misuse that kills the beneficial insects, and interference from organized crime in favela release zones.
- Where the wolbitos have been deployed, results are striking — dengue cases fell 89% in Niterói and 63% in Campo Grande — but over 200 million Brazilians remain unprotected.
- Expansion to 54 new cities is planned for this year, yet scientists and health officials warn that the method is one tool among many, not a standalone solution, and the race against the virus is far from won.
Inside a sweltering breeding facility in Curitiba, scientist Luciano Moreira tends to cages of mosquitoes fed on warm horse blood and sugar water. These are no ordinary insects — each carries Wolbachia, a bacterium that prevents them from transmitting dengue, Zika, and chikungunya. The facility, the largest of its kind in the world, produces 100 million infected eggs per week. Released into cities, these "wolbitos" gradually displace wild mosquito populations, quietly dismantling the disease's transmission chain.
The results, where the method has been applied, are remarkable. Dengue cases fell 89% in Niterói and 63% in Campo Grande. Since Moreira began testing the approach in 2011, an estimated six million Brazilians have been shielded from a disease so painful it is called "breakbone fever" — one capable of escalating into hemorrhagic fever and death. In 2024 alone, more than 6,000 people died in a single outbreak.
Yet the virus is moving faster than the solution. Climate change has extended dengue's reach into Brazil's previously cool southern regions, and more than 200 million people remain at risk. The bio-factory itself had to reduce output because the health ministry's requests did not match production capacity. In Rio de Janeiro, poor coordination between agencies, the misapplication of larvicides lethal to the beneficial mosquitoes, and obstruction by organized crime in favela neighborhoods have all eroded the program's effectiveness.
Moreira, now 59 and recognized by both Nature and Time as one of the world's most influential scientists, is measured in his ambitions. The wolbitos, he insists, are not a cure-all but a complement to vaccines — including Brazil's own single-dose dengue vaccine, the first of its kind globally. This year, the program expands to 54 new cities, bringing the total to 70. The science is sound, the factory is running, and the insects are winning wherever they are deployed. But the territory the virus is claiming grows faster than the territory the wolbitos can reach.
In a sweltering breeding facility in Curitiba, Luciano Moreira moves carefully between cages of mosquitoes, each one carrying a bacterium that renders it incapable of spreading dengue. The insects are fed a mixture of warm horse blood and sugar water, kept in translucent fabric enclosures under precisely controlled heat. This is the world's largest factory for what scientists call "wolbitos"—Aedes aegypti mosquitoes infected with Wolbachia, a microorganism that blocks viral transmission. The operation can produce 100 million eggs per week, each destined for cities across Brazil where they will be released to gradually displace the wild mosquitoes that carry dengue, Zika, and chikungunya.
It is an elegant solution to an ancient problem, and it works. In the city of Niteroi near Rio de Janeiro, dengue cases dropped 89 percent after the wolbitos were introduced. In Campo Grande, the decline reached 63 percent. Since Moreira first began testing the method in 2011, an estimated six million Brazilians have been protected from a disease that causes debilitating joint and bone pain—so severe it earned the nickname "breakbone fever." In severe cases, dengue triggers hemorrhagic fever and death. During the 2024 outbreak alone, more than 6,000 people died.
Yet the virus is winning the race. More than 200 million Brazilians remain at risk, and the disease is spreading faster than the factory can breed and ship insects to contain it. Climate change has redrawn the map of dengue's reach. Regions in the south that were once too cold to sustain the virus now face regular outbreaks. "The virus accelerates with climate change," Moreira, now 59, explained. "In the south, which used to be much colder, there was no dengue before, but now there is." The method he helped pioneer in Australia in 2008 is being outpaced by the very conditions that make it necessary.
The bio-factory itself, opened in 2025, represents a remarkable feat of applied biology. Employees work in sweat-soaked conditions to maintain the precise temperature the mosquitoes require. The facility operates under strict secrecy—no photographs are permitted of the equipment or processes—to protect the intellectual property of the Wolbachia technique. The eggs are stored in capsules and shipped to urban areas where they hatch and begin their slow work of genetic displacement, their reproductive advantage gradually replacing wild populations.
But breeding capacity is only part of the problem. The Brazilian government has recognized the wolbitos as a legitimate public health tool, yet bureaucratic machinery has failed to keep pace with production. "The factory had to scale back production because demand from the health ministry wasn't that high," Moreira said. In Rio de Janeiro, implementation has been hampered by institutional failures and poor coordination between agencies. Local health teams have applied larvicides that harm the Wolbachia-infected insects, undermining their effectiveness. In the city's sprawling favelas, organized crime has interfered with mosquito releases entirely.
Ludimila Raupp, an epidemiologist at the Pontifical Catholic University of Rio, acknowledged the "urgent need" to expand the program while recognizing that it "is not easy." The challenges are technical, operational, logistical, and financial, according to Brazil's Health Minister Alexandre Padilha. Moreira himself is careful not to oversell the approach. The wolbitos are not a cure-all, he insists, but rather one tool among several—complementary to vaccines, which Brazil developed as the world's first single-dose dengue vaccine, with India close behind in testing another.
This year, the program will expand to 54 new cities, bringing the total number of participating municipalities to 70. Moreira was recognized by Nature magazine in 2025 as one of the world's top ten scientists, and Time named him one of its 100 most influential people. Yet recognition has not translated into the resources or coordination needed to match the speed of the virus. The wolbitos are winning in the places where they are deployed, but the disease is spreading into territory they have not yet reached. The race continues, and the outcome remains uncertain.
Notable Quotes
Climate change accelerates the spread of the virus. In the south, which used to be much colder, there was no dengue before, but now there is.— Luciano Moreira, scientist
The method is not a magic bullet against dengue, but rather a strategy that is complementary to other measures, such as vaccines.— Luciano Moreira
The Hearth Conversation Another angle on the story
Why is the factory in Curitiba producing at less than full capacity if the need is so urgent?
Because the health ministry hasn't ordered enough. The factory can make 100 million eggs a week, but demand from the government side has been weak. It's a gap between what's possible and what's actually being requested.
That seems like a straightforward bureaucratic failure. Why hasn't it been fixed?
It's more tangled than that. State health systems have their own budgets, their own priorities, their own ways of doing things. Getting 70 municipalities to coordinate on a single strategy is harder than it sounds, especially when some are using larvicides that actually harm the wolbitos.
So the government is simultaneously undermining its own solution?
Not intentionally. Local teams are following protocols they've always followed. But yes, the left hand doesn't know what the right hand is doing. And in Rio's favelas, there's another layer—organized crime makes it dangerous to release mosquitoes in certain areas.
Is Moreira frustrated by this?
He seems pragmatic about it. He's careful to say the wolbitos aren't a magic bullet. They work best as part of a larger strategy that includes vaccines and other measures. But the gap between what the science can do and what the system can actually deploy—that's real.
What happens if the expansion to 54 new cities this year doesn't happen?
The virus keeps spreading into unprotected territory. Climate change is already pushing dengue into regions that were safe a decade ago. The window to contain it narrows.